Hybio Pharmaceutical Co., Ltd. (300199.SZ) SHZ
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 16.37B |
| Enterprise Value | 17.92B |
| P/E Ratio | 195.79 |
| PEG Ratio | -0.11 |
| Price/Sales Ratio | 18.93 |
| Price/Book Ratio | 25.21 |
| Enterprise/Revenue | 20.7 |
| Enterprise/EBITDA | 64.43 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.16 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 966.35M |
| Revenue/Share | 1.05 |
| Gross Profit | 564M |
| EBITDA | 295.01M |
| Net Income | 36.57M |
| Diluted EPS | 0.04 |
Balance Sheet
| Total Cash | 108.74M |
| Total Cash/Share | 0.12 |
| Total Debt | 1.8B |
| Total Debt/Equity | 2.43 |
| Current Ratio | 0.43 |
| Book Value Per Share | 0.83 |
Price History
| 52-Week Change | -15.79 |
| 52-Week High | 31.19 |
| 52-Week Low | 16.23 |
| Moving Average 50 Days | 22.7 |
| Moving Average 200 Days | 20.34 |
Statistics
| Average Volume | 52.77M |
| Shares Outstanding | 883.24M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 1.03 |
| Last Split Factor | 2:1 |
| Last Split Date | April 14, 2015 |
AD
